sulforaphane has been researched along with Gout in 1 studies
sulforaphane: from Cardaria draba L.
sulforaphane : An isothiocyanate having a 4-(methylsulfinyl)butyl group attached to the nitrogen.
Gout: Metabolic disorder characterized by recurrent acute arthritis, hyperuricemia and deposition of sodium urate in and around the joints, sometimes with formation of URIC ACID calculi.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aetiology of gout is closely linked to the deposition of monosodium uric acid (MSU) crystals and the consequent activation of the NOD-like receptor family, pyrin domain containing 3 (NLRP3) inflammasome." | 7.88 | Suppression of NLRP3 inflammasome by oral treatment with sulforaphane alleviates acute gouty inflammation. ( Cho, YY; Kang, HC; Lee, HE; Lee, HS; Lee, JY; Yang, G; Yeon, SH, 2018) |
| "The aetiology of gout is closely linked to the deposition of monosodium uric acid (MSU) crystals and the consequent activation of the NOD-like receptor family, pyrin domain containing 3 (NLRP3) inflammasome." | 3.88 | Suppression of NLRP3 inflammasome by oral treatment with sulforaphane alleviates acute gouty inflammation. ( Cho, YY; Kang, HC; Lee, HE; Lee, HS; Lee, JY; Yang, G; Yeon, SH, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yang, G | 1 |
| Yeon, SH | 1 |
| Lee, HE | 1 |
| Kang, HC | 1 |
| Cho, YY | 1 |
| Lee, HS | 1 |
| Lee, JY | 1 |
1 other study available for sulforaphane and Gout
| Article | Year |
|---|---|
Suppression of NLRP3 inflammasome by oral treatment with sulforaphane alleviates acute gouty inflammation.
Topics: Acute Disease; Administration, Oral; Animals; Anticarcinogenic Agents; Cells, Cultured; Disease Mode | 2018 |